Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with more than 81 active research sites across the globe. It is the second largest clinical research site organization globally. Its member companies have over 100 years of combined experience and have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.